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ABSTRACT: Beta-lactamase producing bacteria have become a public health burden due to antibiotics usage 
in livestock production. This study was carried out to detect extended spectrum beta-lactamase (ESBL) and 
metallo-beta-lactamase (MBL) producing Pseudomonas spp. from poultry droppings and piggery dung in 
Ibadan. Poultry droppings and piggery dung were collected from the University of Ibadan livestock farms 
while isolation of Pseudomonas spp. was done using Pseudomonas base agar supplemented with 
Pseudomonas C-N supplement and were conventionally characterized. Detection of ESBL and MBL 
producing isolates were by double disc synergy test and imipenem-EDTA combined disc test respectively. 
Antimicrobial susceptibility test was by disc diffusion method against trimethoprim (5 µg), amoxicillin/ 
clavulanate (30 µg), cefotaxime (30 µg), ceftazidime (30 µg), cefepime (30 µg), aztreonam (30 µg), imipenem 
(10 µg), gentamicin (10 µg) and ciprofloxacin (10 µg). A total of 108 Pseudomonas spp. were isolated 
comprising 53.7% from poultry droppings and 46.3% from piggery dung. The isolates include P. aeruginosa 
(63.0%), P. putida (24.0%) and P. stutzeri (13.0%). While the ESBL producers were P. aeruginosa (10.2%) 
and P. stutzeri (1.9%), none of the isolates produced MBL. However, 63.6% the ESBL producers showed 
resistance to trimethoprim while 61.5% were multidrug resistant. The high prevalence of antibiotics resistance 
and multidrug resistant strains observed among the Pseudomonas spp. infer that poultry droppings and 
piggery dung can serves as a reservoir for growth and dissemination of clinically significant antibiotics 
resistance among bacterial species. 
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1. INTRODUCTION 
The use of antibiotics in livestock production has aggravated the risk factor associated with the 
development and distribution of antibiotics resistance from animal husbandry [1]. Antibiotic resistance is a 
worldwide problem and new forms of antibiotic resistance emerges each year which has cross international 
boundaries and spread between continents with ease. The World Health Organisation (WHO) described 
antibiotic-resistant bacteria as “nightmare bacteria” or “superbugs” that pose catastrophic threat to the public 
health [2]. According to the United State report, it was estimated that at least 2,049,442 illnesses were caused 
by antibiotics resistant infections resulting into about 23,000 deaths [3]. The use of antibiotics in agricultural 
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settings has been reported to exert selective pressure which favours the survival of resistant strains of bacteria 
over susceptible ones, resulting to increase in resistant bacteria within the microbial communities [4].  
 Antibiotics has been reported to be widely and indiscriminately used in Nigeria as additives to feeds 
and water, to treat diseases and promote animal growth in livestock production [5, 6]. This practice has led to 
increase in the emergence of antibiotics resistant in livestock production such as poultry and piggery. More so, 
majority of the animal  farms in Nigeria have no waste treatment facility, hence,  all the waste generated in the 
farm are either dumped in a farmland or in a remote area such as in or close to water bodies [7]. Wastes 
generated from the livestock are also used as feed supplement to generate maggot for feeding fishes in 
aquaculture. This could constitute threat to humans inhabiting the vicinities where these animal wastes are 
dumped because of the possibilities of being exposed to antibiotics resistant bacteria in the waste.  
 Pseudomonas species are emerging opportunistic pathogen of clinical importance that survives in 
harsh conditions and are also reported to be naturally resistant to penicillin and most related beta-lactam 
antibiotics. Pseudomonas aeruginosa is one of the bacteria most frequently responsible for nosocomial and 
community acquired infections. Development of resistance to β-lactams in clinical strains of P. aeruginosa 
has been reported to be associated with the production of acquired β-lactamases, constitutive overproduction 
of the cephalosporinase, AmpC or non-enzymatic mechanisms such as drug efflux or outer membrane 
impermeability [8, 9]. 
 Extended spectrum beta-lactamase and metallo-beta-lactamase production have been reported as some 
of the mechanisms that leads to the increase in resistance of Pseudomonas spp. to beta-lactam drugs [10]. A 
lot of studies have investigated the occurrence of ESBL and MBL producing Enterobacteriaceae in livestock 
waste but there is dearth of information of ESBL and MBL producing Pseudomonas spp. in livestock wastes. 
Hence, the present study is aimed at determining the occurrence of ESBL and MBL producing Pseudomonas 
spp. isolated from poultry droppings and piggery dung in Ibadan, Nigeria. 
2. MATERIALS AND METHODS 
2.1. Sampling site and sample collection 
 Poultry droppings and piggery dung were collected from the University of Ibadan poultry farm 
(latitude 7.4401, longitude 3.900) and piggery farm (latitude 7.4401, longitude 3.8996) between the months of 
March and April 2018. The samples were labeled appropriately, preserved in ice packs and transported to 
Environmental Laboratory, Department of Microbiology University of Ibadan for immediate analyses. 
2.2. Isolation and identification of the Pseudomonas species 
 Isolation of Pseudomonas species was done using the standard pour plate technique on Pseudomonas 
base agar (CM0559, Oxoid, Basingstoke, UK) supplemented with pseudomonas C-N supplement (SR102, 
Oxoid, Basingstoke, UK) a selective medium for the isolation of the Pseudomonas species. The inoculated 
plates were incubated at 37oC for 48 hours. Distinct bacteria growth with either bluish or yellowish green 
pigment, irregular margin, smooth or crenate or rugose surface, semi translucent or raised colony were selected 
as probable Pseudomonas spp. and sub cultured by repeated streaking on nutrient agar to obtain the pure 
culture. Characterization of these isolates was done based on their distinct pigment production and 
conventional biochemical tests [11]. 
2.3. Screening for potential extended spectrum beta-lactamase producing Pseudomonas species 
 Potential ESBL-producing Pseudomonas spp. screening was done using ceftazidime (30 μg) and 
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cefotaxime (30 μg). Isolates showing reduced susceptibility to at least one of these drugs with zone of 
inhibition for ceftazidime ≤ 22 mm and cefotaxime ≤ 27 mm were considered as potential ESBL producing 
strains [12]. 
2.4. Phenotypic detection of extended spectrum beta-lactamase producing Pseudomonas species 
 Pseudomonas species that were suspected to be potential ESBL producers were confirmed for ESBL 
production using the double disk synergy test [13]. Sterile cotton swab was used to inoculate the standardized 
inoculum (corresponding to 0.5 McFarland standard) on Mueller Hinton agar plate. Two disks of 3rd 
generation cephalosporins (ceftazidime 30 μg, cefotaxime 30 μg) and fourth generation cephalosporin 
(cefepime 30 μg) disks were placed at 20 mm distance center to center from amoxicillin/clavulanate (30 μg) 
disk preceding incubation for 18-24 hours at 35°C. Augmentation of the zone of inhibition of any one of the 
three cephalosporin antibiotics disks towards amoxicillin/clavulanate indicated the presence of extended-
spectrum beta-lactamases. 
2.5. Antibiotics susceptibility test of the extended spectrum beta-lactamase producing Pseudomonas 
isolates 
 Antibiotic susceptibility test of the ESBL producing Pseudomonas species was carried out against nine 
antimicrobial agents using the standard Kirby-Bauer disc diffusion method [12]. The antibiotics used include 
the following classes of antibiotics: beta-lactam inhibitor (amoxicillin/clavulanate 30 μg), broad spectrum 
cephalosporin from the 3rd and 4th generation (ceftazidime 30 μg, cefotaxime 30 μg, and cefepime 30 μg), 
monobactam (aztreonam 30 μg), carbapenem (imipenem 10 μg), aminoglycosides (gentamicin 10 μg), 
fluoroquinolone (ciprofloxacin 5 μg), and folate pathway inhibitor (trimethoprim 5 µg).The antibiotic disks 
were placed on Mueller Hinton agar plates inoculated with the standardized inoculum and incubated at 35oC 
for 18-24 hours. The zones of inhibition were measured in millimeter and interpreted based on CLSI 
guidelines [12]. Isolates showing resistance to at least three different classes of antibiotics were considered as 
multidrug resistant strains [14]. 
2.6. Phenotypic detection of metallo β-lactamase (MβL) activity in ESBL-producing Pseudomonas 
species 
 Imipenem resistant ESBL-producing Pseudomonas isolates were tested for MBL production using 
imipenem and ethylenediaminetetraacetate (EDTA) combined disk test. Two imipenem disks were placed at a 
distance of 5 cm from each other on Mueller Hinton agar plate inoculated with the standardized inoculum and 
10 μl of 0.5 M EDTA solution were added to one of the imipenem disk. Any of the isolates that showed 
increase of zone of inhibition ≥7 mm between imipenem+EDTA disk in comparison with the imipenem disk 
alone after 18-24 hours incubation were considered MBL producers [15]. 
3. RESULTS 
 A total of 108 Pseudomonas spp. were isolated comprising 58 (53.7%) from poultry droppings and 50 
(46.3%) form piggery dung. Identification of the isolates showed that 63.0% of the Pseudomonas species 
were P. aeruginosa, 24.0% were P. putida while 13.0% were P. stutzeri (Table 1). The ESBL producers were 
P. aeruginosa (10.2%) and P. stutzeri (1.9%), while none of the isolates produced MBL (Table 2). The result 
of the antibiotics susceptibility test showed that 71.4% and 50.0% of the ESBL producing P. aeruginosa 
isolated from poultry droppings and piggery dung were resistant to trimethoprim respectively. Furthermore, 
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28.6% of the ESBL producing P. aeruginosa from the poultry droppings showed resistance to the following 
antibiotics: amoxicillin/clavulanate, ceftazidime, imipenem and ciprofloxacin. It was also observed that 
42.9% of the ESBL producing P. aeruginosa were resistant to gentamicin and cefotaxime respectively, while 
none of the isolates exhibited resistance to cefepime and aztreonam.  
 
Table 1. Prevalence of the Pseudomonas species isolated from the poultry droppings and piggery dung. 
Samples 
Isolates 
n (%) 
Total 
n (%) 
P. aeruginosa P. stutzeri P. putida  
Poultry droppings 32 (47.1) 7 (50.0) 19 (73.1) 58 (53.7) 
Piggery dung 36 (52.9) 7 (50.0) 7 (26.9) 50 (46.3) 
Total 68 (63.0) 14 (13.0) 26 (24.0) 108 (100) 
 
Table 2. Extended Spectrum Beta-lactamase producing Pseudomonas spp. from the poultry droppings and piggery dung. 
Samples No. of isolates 
screened 
ESBL producing Pseudomonas species n (%) Total  
n (%) P. aeruginosa P. stutzeri P. putida 
Poultry droppings 58 7 (12.1) 1 (1.7) 0 (0) 8 (13.8) 
Piggery dung 50 4 (8.0) 1 (2.0) 0 (0) 5 (10.0) 
Total 108 11 (10.2) 2 (1.9) 0 (0) 13 (12.0) 
 
Table 3. Antibiotics resistance pattern of the ESBL-producing Pseudomonas spp. 
Antibiotics 
ESBL positive isolates from each samples, n (%) 
Pseudomonas aeruginosa Pseudomonas stutzeri 
Poultry 
droppings 
(n=7) 
Piggery 
dung (n=4) 
Total 
(n=11) 
Poultry 
droppings 
(n=1) 
Piggery dung 
(n=1) 
Total 
(n=2) 
TMP 5 (71.4) 2 (50.0) 7 (63.6) 0 (0.0) 1 (100) 1 (50.0) 
AMC 2 (28.6) 3 (75.0) 5 (45.5) 0 (0.0) 1 (100) 1 (50.0) 
CTX 3 (42.9) 1 (25.0) 4 (36.4) 0 (0.0) 1 (100) 1 (50.0) 
CAZ 2 (28.6) 3 (75.0) 5 (45.5) 0 (0.0) 1 (100) 1 (50.0) 
FEP 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (100) 1 (50.0) 
ATM 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
IPM 2 (28.6) 0 (0.0) 2 (18.2) 0 (0.0) 0 (0.0) 0 (0.0) 
GEN 3 (42.9) 1 (25.0) 4 (36.4) 1 (100) 0 (0.0) 1 (50.0) 
CIP 2 (28.6) 0 (0.0) 2 (18.2) 1 (100) 0 (0.0) 1 (50.0) 
Key: TMP = Trimethoprim (5 µg), AMC = Amoxicillin/Clavulanate (30 µg), CTX = Cefotaxime (30 µg), CAZ = 
Ceftazidime (30 µg), FEP = Cefepime (30 µg), ATM = Aztreonam (30 µg), IMP = Imipenem (10 µg), GEN = Gentamicin 
(10 µg), CIP = Ciprofloxacin (5 µg). 
 
 In addition, 75.0% of the ESBL producing P. aeruginosa from the piggery dung were resistant to 
amoxicillin/clavulanate and ceftazidime; 25.0% to cefotaxime and gentamicin while none of these isolates 
showed resistance to cefepime, imipenem and gentamicin. Furthermore, the two P. stutzeri isolated from the 
poultry dropping that produced ESBL also showed resistance to trimethoprim, amoxicillin/clavulanate, 
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cefotaxime, ceftazidime and cefepime. More so, one of the two (50.0%) P. stutzeri that was isolated from 
piggery dung showed resistance to trimethoprim, amoxicillin/clavulanate, cefotaxime, ceftazidime, cefepime, 
gentamicin and ciprofloxacin (Table 3). The Antibiotypes of the ESBL-producing Pseudomonas species 
showed that eight (61.5%) of the isolates that produced ESBL and showed resistance to antibiotics were 
multidrug resistance. In addition, two P. aeruginosa were resistant to three different antibiotics that include 
TMP-AMC-CTX and one P. stutzeri also showed resistance to five different antibiotics including TMP-AMC-
CTX-CAZ-FEP (Table 4). 
 
Table 4. Antibiotypes of the ESBL-producing Pseudomonas species. 
Antibiotypes Classes of Antibiotics P. aeruginosa P. stutzeri Total 
CAZ 1 2 0 2 (15.4) 
IMP 1 1 0 1 (7.7) 
AMC-CAZ 2 1 0 1(7.7) 
GEN-CIP 2 0 1 1(7.7) 
TMP-AMC-CTX 3 2 0 2(15.4) 
TMP-AMC-CAZ 3 1 0 1(7.7) 
TMP-CAZ-GEN 3 1 0 1(7.7) 
TMP-CTX-GEN 3 1 0 1(7.7) 
TMP-AMC-CTX-GEN 4 1 0 1(7.7) 
TMP-IMP-GEN-CIP 4 1 0 1(7.7) 
TMP-AMC-CTX-CAZ-FEP 5 0 1 1(7.7) 
Key: TMP = Trimethoprim (5 µg), AMC = Amoxicillin/Clavulanate (30 µg), CTX = Cefotaxime (30 µg), CAZ = 
Ceftazidime (30 µg), FEP = Cefepime (30 µg), ATM = Aztreonam (30 µg), IMP = Imipenem (10 µg), GEN = Gentamicin 
(10 µg), CIP = Ciprofloxacin (5 µg). 
 
4. DISCUSSION 
 In the present study, the production of ESBL producing Pseudomonas species isolated from poultry 
waste and piggery was determined. The observation from this study that showed the occurrence of                          
P. aeruginosa being the highest (63.0%) followed by P. putida (24.0%) and P. stutzeri (13.0%) is in agreement 
with the occurrence of similar isolates from  a study on clinical samples in Bangladesh in which the 
occurrence of P. aeruginosa was higher than other species [16]. However, this is not in agreement with a 
report from a study carried out on water samples in Danube where the most prevalent isolate was P. putida 
and P. aeruginosa was the least [17]. The disparity may be attributed to different studied samples. 
Furthermore, the  findings from this present study that showed 12.1% and 8.0% of the P. aeruginosa isolated 
from the poultry droppings and piggery waste being ESBL producers contradicts  the report from  another 
study on cattle fecal sample in Benin city, Nigeria where none of the P. aeruginosa was reported to have 
produced ESBL [18]. While the present study was on poultry droppings and piggery waste which could have 
been responsible for the observed difference, the numbers of isolates (10) considered in the latter study 
compared to the 108 isolates in this study might be responsible for the inability to detect ESBL producers. In 
addition, the 10.2% ESBL producing P. aeruginosa observed in this study is lower compared to the 27.5% 
ESBL producing P. aeruginosa reported in a previous study on clinical isolates in Egypt [19]. This noticeable 
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difference is not strange because a higher resistance to antibiotics including ESBL production is expected 
from clinical isolates compared to isolates from environmental samples.  
The observation from this study that none of the ESBL producing Pseudomonas spp. produced MBL is 
in agreement with the report of a study on human urine, pus, body fluids, sputum and blood where none of the 
ESBL producing isolates also produced MBL [20]. The high resistance of P. stutzeri (100%) and                              
P. aeruginosa (71.4%) from piggery dung and poultry droppings to trimethoprim in this study is of great 
concern. Although, trimethoprim has not been reported to be widely used in animal husbandry especially in 
Nigeria, sulphonamides has been reported to be widely used [21]; hence, resistance to trimethoprim might 
have co-evolved with resistance to sulphonamides since they  have the same mechanism of action (inhibition 
of foliate synthase pathway). In addition, the intrinsic resistance possessed by Pseudomonas spp. against 
trimethoprim and the fact that the antibiotic is bacteriostatic might also be responsible for the higher 
resistance observed by P. aeruginosa and P. stutzeri to trimethoprim in this study.  
 In this present study, the observed high resistance of P. stutzeri and P. aeruginosa from piggery dung to 
amoxicillin/clavulanate which were 100.0% and 75.0% is similar to the report of a study on hospital drains in 
South Africa [22]. However, a lower resistance of P. aeruginosa (28.6%) and P. stutzeri (0%) among the 
ESBL producers from the poultry droppings to amoxicillin/clavulanate was obtained compared to the 90.0% 
previously reported from a study also on poultry droppings in Nigeria [23]. The reason for the differences 
may be as a result of different studied isolates; the latter study was on E. coli while the present study was on 
Pseudomonas spp. Similarly, the 28.6% and 0% resistance of ESBL producing P. aeruginosa and P. stutzeri 
respectively from the poultry droppings in this study to cefotaxime and ceftazidime is far lower compared to 
the 100% resistance reported on similar isolates in a study on clinical isolates in Nigeria and the 100% 
resistance of P. aeruginosa from a study on camel meat in Egypt [24, 25]. One of the reasons for the disparity 
may be the method of bacterial isolation, while in the latter study, the third generation cephalosporin 
(ceftazidime and cefotaxime) was incorporated into media for isolation, Pseudomonas spp. were isolated 
without the incorporation of any antibiotics in the present study to prevent eliminating species that may be 
susceptible to these antibiotics but resistant to others. Therefore incorporating antibiotics in medium for 
isolation might have exerted selective pressure for the survival of resistance strains over susceptible ones such 
that those isolated strains showed higher resistance to the incorporated antibiotics than other antibiotics.  
 Furthermore, the observation from this study that none of the P. aeruginosa obtained from the studied 
samples showed resistance to cefepime is in agreement with the report of another study on poultry droppings 
and cow dung in South-west Nigeria [24]. However, this finding is in contrast to the report of another study 
carried out in India on various clinical samples with the resistance of 74.0% of the Pseudomonas isolates to 
cefepime [26]. This may be an indication that the usage of cefepime is more in human medicine than in 
veterinary medicine.  
 Also, that none of the P. aeruginosa and P. stutzeri in this study was observed to have exhibited any 
resistance to imipenem is similar to the previously reported resistant patterns of the isolates from poultry 
droppings and cow dung collected from different geographical location in South-western Nigeria [24]. 
However, this finding is not in agreement with other studies from which it was reported that 8.7% and 1.6% 
showed resistance to imipenem from a study on bovine meat in Abidjan and dairy farm samples in 
Nottingham [27, 28]. The low resistance of Pseudomonas species to carbapenems such as imipenem observed 
in the studied samples in this present study as well as other environmental samples in other studies may be 
because carbapenems are considered as antimicrobial agent of last resort and effective against the treatment of 
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infections caused by ESBL-producing bacteria. These antibiotics are able to resist the hydrolytic activity of 
beta-lactamase enzymes [29, 30]. Furthermore, resistance of P. aeruginosa isolated from poultry droppings 
observed in the present study to gentamicin (42.9%) and ciprofloxacin (26.8%), is comparably similar to the 
39.0% resistance reported from a previous study carried out on clinical samples in India [31]. Meanwhile, 
resistance to these antibiotics by P. aeruginosa has been previously reported to be linked to the mutation in 
the gyrA gene encoding the A subunit of the target enzyme, DNA gyrase [32]. The observed multidrug 
resistance (61.5%) of the ESBL producing Pseudomonas spp. in the present study is high and is also 
comparably similar to the 75.8% reported from Egypt on a study on clinical samples [19]. Such multiple 
antibiotics resistant in Pseudomonas spp. has been attributed to combination of acquisition of resistance gene 
through genetic exchange and mutation, as well as physiological mechanism such as the possession of specific 
protein, poor membrane permeability, biofilm formation and efflux pumps [33-35]. 
5. CONCLUSION 
 The high prevalence of antibiotics resistance as well as multidrug resistance strains of Pseudomonas 
spp. in this study is an indication that both the poultry droppings and piggery dung can serves as a reservoir 
for the development and dissemination of clinically significant antibiotics resistant among bacterial 
pathogens. Therefore, cautious efforts should be made to limit the misuse of  antibiotics in animal husbandry 
and proper discharge of livestock waste into the environment should be enforce in other reduce emergence of  
antibiotics resistant organisms that can lead to outbreak of infection by antibiotics resistant bacteria.  
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